News
Hosted on MSN26d
Clinical trial: Adjuvant tamoxifen may reduce recurrence risk for patients with 'good-risk' DCIS who forgo radiationAfter a median follow-up of almost 15 years, 117 cases of ipsilateral (same breast) recurrence were diagnosed. The estimated 15-year risk of ipsilateral recurrence was 11.4% for patients treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results